But a question I would have would be with this method is it purely a Yes or No test? Can it distinguish the degree to which it is testing for is present? For example, in a Recaf test, how much above the specific individual's baseline is present? Can the intensity of a color do this or even hint at it? Can it be quantified to eliminate false positives or must a "positive" only mean that further testing is required?
In any case, if it can be commercialized everybody benefits and is a significant step in the arsenal of dealing with cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.